Walleye Trading
XBI icon

Walleye Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Walleye Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.1M Sell
556,600
-128,200
-19% -$16M 0.12% 164
2025
Q4 		$83.5M Buy
684,800
+163,200
+31% +$18.7M 0.12% 172
2025
Q3 		$52.3M Buy
521,600
+217,700
+72% +$19.6M 0.08% 248
2025
Q2 		$25.2M Buy
303,900
+202,000
+198% +$16.1M 0.05% 439
2025
Q1 		$8.26M Sell
101,900
-174,700
-63% -$15.6M 0.02% 833
2024
Q4 		$24.9M Buy
276,600
+8,200
+3% +$794K 0.05% 395
2024
Q3 		$26.5M Sell
268,400
-204,500
-43% -$20.1M 0.06% 358
2024
Q2 		$43.8M Buy
472,900
+180,700
+62% +$16.2M 0.1% 188
2024
Q1 		$27.7M Buy
292,200
+169,000
+137% +$15.7M 0.06% 319
2023
Q4 		$11M Buy
123,200
+44,000
+56% +$3.27M 0.02% 735
2023
Q3 		$5.78M Sell
79,200
-29,000
-27% -$2.32M 0.02% 1016
2023
Q2 		$9M Sell
108,200
-122,500
-53% -$10.2M 0.03% 631
2023
Q1 		$17.6M Buy
230,700
+118,600
+106% +$9.84M 0.04% 425
2022
Q4 		$9.3M Buy
112,100
+6,800
+6% +$551K 0.03% 705
2022
Q3 		$8.35M Buy
105,300
+54,200
+106% +$4.57M 0.03% 713
2022
Q2 		$3.79M Buy
51,100
+24,400
+91% +$1.83M 0.01% 1194
2022
Q1 		$2.4M Sell
26,700
-12,800
-32% -$1.18M 0.01% 1534
2021
Q4 		$4.42M Buy
39,500
+34,100
+631% +$4.11M 0.01% 1061
2021
Q3 		$679K Buy
5,400
+3,800
+238% +$489K ﹤0.01% 2619
2021
Q2 		$217K Sell
1,600
-5,900
-79% -$776K ﹤0.01% 3835
2021
Q1 		$1.02M Buy
+7,500
New +$1.12M ﹤0.01% 1899
2020
Q3 		– Sell
-3,100
Closed -$347K – 4691
2020
Q2 		$347K Buy
3,100
+1,700
+121% +$167K ﹤0.01% 2588
2020
Q1 		$108K Sell
1,400
-90,700
-98% -$8.03M ﹤0.01% 3061
2019
Q4 		$8.76M Buy
92,100
+82,300
+840% +$7.12M 0.06% 333
2019
Q3 		$747K Buy
9,800
+2,100
+27% +$175K 0.01% 1815
2019
Q2 		$675K Sell
7,700
-12,100
-61% -$1.03M 0.01% 1936
2019
Q1 		$1.79M Buy
19,800
+2,100
+12% +$179K 0.01% 1175
2018
Q4 		$1.27M Sell
17,700
-3,400
-16% -$274K 0.01% 1469
2018
Q3 		$2.02M Sell
21,100
-39,100
-65% -$3.79M 0.01% 1328
2018
Q2 		$5.73M Buy
60,200
+16,000
+36% +$1.47M 0.03% 534
2018
Q1 		$3.88M Buy
44,200
+4,500
+11% +$411K 0.02% 687
2017
Q4 		$3.37K Buy
39,700
+18,700
+89% +$1.57M 0.02% 918
2017
Q3 		$1.82K Sell
21,000
-8,100
-28% -$649K 0.01% 1360
2017
Q2 		$2.25K Buy
29,100
+19,500
+203% +$1.38M 0.01% 1117
2017
Q1 		$666 Sell
9,600
-5,200
-35% -$349K ﹤0.01% 2000
2016
Q4 		$876K Sell
14,800
-31,300
-68% -$1.93M 0.01% 1621
2016
Q3 		$3.06M Buy
+46,100
New +$2.85M 0.02% 690

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walleye Trading's XBI Position: Q1 2026 in Review

Walleye Trading increased its State Street SPDR S&P Biotech ETF (XBI) stake by 190% in Q1 2026, buying an estimated $23.5M and bringing the position to 287,721 shares worth $36.8M. The position accounts for 0.06% of the portfolio, ranked #311.

Walleye Trading first reported a position in XBI in Q1 2017 and has held it in 23 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Walleye Trading held 287,721 shares of State Street SPDR S&P Biotech ETF worth $36.8M as of Q1 2026.
  • Walleye Trading bought 188,401 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $23.5M.
  • State Street SPDR S&P Biotech ETF made up 0.06% of Walleye Trading's portfolio in Q1 2026, its #311 holding.
  • Walleye Trading first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 23 quarters since.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.